Initially, OSF launched Digital Diagnostics’ Luminetics Core at eight sites. However, after successfully integrating the tool, the health system expanded its use to 24 additional sites, which have been operating with it for nine months, according to a Sept. 12 OSF news release.
The platform analyzes retinal images for signs of disease. So far, OSF has been able to inform 25 percent of nearly 1,500 diabetic patients that they tested positive for diabetic retinopathy.
“We are always seeking new ways to innovate and improve access to cutting-edge diagnostics for our patients so we can help them better manage their health conditions, including diabetes which impacts nearly 66,000 OSF patients,” Mark Meeker, DO, vice president of Community Medicine for OSF HealthCare, said in the news release. “Working with Digital Diagnostics allows us to offer an expanded set of services to our patients while empowering our clinicians to help their patients decrease disease progression through prevention, not just through treatment.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
